Effect of genetic background on the dystrophic phenotype in mdx mice

Human Molecular Genetics

Volumn 25, Issue 1, 2016, Pages 130-145

  Coley, William D ^a   Bogdanik, Laurent ^b   Vila, Maria Candida ^a,c   Yu, Qing ^a   Van Der Meulen, Jack H ^a   Rayavarapu, Sree ^a   Novak, James S ^a   Nearing, Marie ^a   Quinn, James L ^a   Saunders, Allison ^b   Dolan, Connor ^b   Andrews, Whitney ^b   Lammert, Catherine ^b   Austin, Andrew ^b   Partridge, Terence A ^a   Cox, Gregory A ^b   Lutz, Cathleen ^b   Nagaraju, Kanneboyina ^a,c  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b JACKSON LABORATORY   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CALCIFICATION; CONGENIC STRAIN; CONTROLLED STUDY; DBA 2 MOUSE; FEMALE; GENETIC BACKGROUND; HEART FUNCTION; HEART MUSCLE; HISTOLOGY; MALE; MOUSE; MUSCLE FUNCTION; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYOSITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKELETAL MUSCLE; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; BODY WEIGHT; C57BL MOUSE; DBA MOUSE; DISEASE MODEL; ECHOCARDIOGRAPHY; GENETICS; HAND STRENGTH; HEART FUNCTION TEST; MUSCLE; MUSCLE CONTRACTION; MUSCLE FIBRIL; ORGAN SIZE; PATHOLOGY; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; DYSTROPHIN; ECHOCARDIOGRAPHY; FEMALE; GENETIC BACKGROUND; HAND STRENGTH; HEART FUNCTION TESTS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED MDX; MUSCLE CONTRACTION; MUSCLES; MUSCULAR DYSTROPHY, ANIMAL; MYOFIBRILS; MYOSITIS; ORGAN SIZE; PHENOTYPE;

EID: 84962204038     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv460     Document Type: Article

References (33)

1. Hatzipetros, T., Bogdanik, L.P., Tassinari, V.R., Kidd, J.D., Moreno, A.J., Davis, C., Osborne, M., Austin, A., Vieira, F.G. and Lutz, C. (2014) C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in themyenteric plexus of the colon without exhibiting key features of ALS. Brain Res., 1584, 59-72
2. Gallagher, M.D., Suh, E., Grossman, M., Elman, L., McCluskey, L., Van Swieten, J.C., Al-Sarraj, S., Neumann, M., Gelpi, E. and Ghetti, B. (2014) TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol., 127, 407-418
3. Heiman-Patterson, T.D., Sher, R.B., Blankenhorn, E.A., Alexander, G., Deitch, J.S., Kunst, C.B., Maragakis, N. and Cox, G. (2011) Effect of genetic background on phenotype variability in transgenic mouse models of amyotrophic lateral sclerosis: a window of opportunity in the search for genetic modifiers. Amyotroph. Lateral Scler., 12, 79-86
4. Heydemann, A., Ceco, E., Lim, J.E., Hadhazy, M., Ryder, P., Moran, J.L., Beier, D.R., Palmer, A.A. and McNally, E.M. (2009) Latent TGF-ß-binding protein 4 modifies muscular dystrophy in mice. J. Clin. Invest., 119, 3703
5. Sicinski, P., Geng, Y., Ryder-Cook, A.S., Barnard, E.A., Darlison, M.G. and Barnard, P.J. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science, 244, 1578-1580
6. Ryder-Cook, A., Sicinski, P., Thomas, K., Davies, K., Worton, R., Barnard, E., Darlison, M. and Barnard, P. (1988) Localization of the mdx mutation within the mouse dystrophin gene. EMBO J., 7, 3017
7. Chamberlain, J.S., Metzger, J., Reyes, M., Townsend, D. and Faulkner, J.A. (2007) Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J., 21, 2195-2204
8. Stedman, H.H., Sweeney, H.L., Shrager, J.B., Maguire, H.C., Panettieri, R.A., Petrof, B., Narusawa, M., Leferovich, J.M., Sladky, J.T. and Kelly, A.M. (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature, 352, 536-539
9. Heydemann, A., Ceco, E., Lim, J.E., Hadhazy, M., Ryder, P., Moran, J.L., Beier, D.R., Palmer, A.A. and McNally, E.M. (2010) Latent TGF-ß-binding protein 4 modifies muscular dystrophy in mice. J. Clin. Invest., 120, 645
10. Fukada, S.-I., Morikawa, D., Yamamoto, Y., Yoshida, T., Sumie, N., Yamaguchi, M., Ito, T., Miyagoe-Suzuki, Y., Takeda, S.I. and Tsujikawa, K. (2010) Genetic background affects properties of satellite cells and mdx phenotypes. Am. J. Pathol., 176, 2414-2424
11. Flanigan, K.M., Ceco, E., Lamar, K.M., Kaminoh, Y., Dunn, D. M., Mendell, J.R., King, W.M., Pestronk, A., Florence, J.M. and Mathews, K.D. (2013) LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann Neurol, 73, 481-488
12. van den Bergen, J.C., Hiller, M., Böhringer, S., Vijfhuizen, L., Ginjaar, H.B., Chaouch, A., Bushby, K., Straub, V., Scoto, M. and Cirak, S. (2014) Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants. J. Neurol. Neurosurg. Psychiatry, 86, 1060-1065
13. Bello, L., Kesari, A., Gordish-Dressman, H., Cnaan, A., Morgenroth, L.P., Punetha, J., Duong, T., Henricson, E.K., Pegoraro, E. and McDonald, C.M. (2015) Genetic modifiers of ambulation in the cooperative international Neuromuscular research group Duchenne natural history study. Ann. Neurol., 77, 684-696
14. Kornegay, J.N., Childers, M.K., Bogan, D.J., Bogan, J.R., Nghiem, P., Wang, J., Fan, Z., Howard, J.F. Jr., Schatzberg, S.J., Dow, J.L. et al. (2012) The paradox of muscle hypertrophy in muscular dystrophy. Phys. Med. Rehabil. Clin. North Am., 23, 149-172., xii
15. Baudy, A.R., Sali, A., Jordan, S., Kesari, A., Johnston, H.K., Hoffman, E.P. and Nagaraju, K. (2011) Non-invasive optical imaging of muscle pathology in mdx mice using cathepsin caged near-infrared imaging. Mol. Imaging Biol., 13, 462-470
16. Saad, A.D., Obinata, T. and Fischman, D.A. (1987) Immunochemical analysis of protein isoforms in thick myofilaments of regenerating skeletal muscle. Dev. Biol., 119, 336-349
17. Selsby, J.T., Morine, K.J., Pendrak, K., Barton, E.R. and Sweeney, H.L. (2012) Rescue of dystrophic skeletal muscle by PGC-1alpha involves a fast to slow fiber type shift in the mdx mouse. PLoS One, 7, e30063
18. Roma, J., Munell, F., Fargas, A. and Roig, M. (2004) Evolution of pathological changes in the gastrocnemius of the mdx mice correlate with utrophin and ß-dystroglycan expression. Acta Neuropathologica, 108, 443-452
19. Haslett, J.N., Sanoudou, D., Kho, A.T., Bennett, R.R., Greenberg, S.A., Kohane, I.S., Beggs, A.H. and Kunkel, L.M. (2002) Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc. Natl Acad. Sci. USA, 99, 15000-15005
20. Duddy, W.J., Cohen, T., Duguez, S. and Partridge, T.A. (2011) The isolated muscle fibre as a model of disuse atrophy: characterization using PhAct, a method to quantify f-actin. Experim. Cell Res., 317, 1979-1993
21. Montagutelli, X. (2000) Effect of the genetic background on the phenotype of mouse mutations. J. Am. Soc. Nephrol., 11, S101-S105
22. Duddy, W., Duguez, S., Johnston, H., Cohen, T.V., Phadke, A., Gordish-Dressman, H., Nagaraju, K., Gnocchi, V., Low, S. and Partridge, T. (2015) Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia. Skeletal Muscle, 5, 1-18
23. Cavalcanti, G.M., Oliveira, A.d. S.B., Assis, T.d. O., Chimelli, L. M.C., Medeiros, P.L.d. and Mota, D.L.d. (2011) Histoquímica y Análisis Morfométrico de las Fibras Musculares de Pacientes con Distrofia Muscular de Duchenne (DMD). Int. J. Morphol., 29, 934-938
24. Lynch, G.S., Hinkle, R.T., Chamberlain, J.S., Brooks, S.V. and Faulkner, J.A. (2001) Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. J. Physiol., 535, 591-600
25. Takeda, A., Jimi, T., Wakayama, Y., Misugi, N., Miyake, S. and Kumagai, T. (1992) Demonstration of cathepsins B, Hand L in xenografts of normal and Duchenne-muscular-dystrophy muscles transplanted into nude mice. Biochem J, 288, 643-648
26. Chen, Y.W., Nagaraju, K., Bakay, M., McIntyre, O., Rawat, R., Shi, R. and Hoffman, E.P. (2005) Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology, 65, 826-834
27. Spurney, C.F., Gordish-Dressman, H., Guerron, A.D., Sali, A., Pandey, G.S., Rawat, R., Van Der Meulen, J.H., Cha, H.J., Pistilli, E.E., Partridge, T.A. et al. (2009) Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Muscle Nerve, 39, 591-602
28. Van den Broek, F. and Beynen, A. (1998) The influence of dietary phosphorus and magnesium concentrations on the calcium content of heart and kidneys of DBA/2 and NMRI mice. Lab. Animals, 32, 483-491
29. Spurney, C.F., Knoblach, S., Pistilli, E.E., Nagaraju, K., Martin, G.R. and Hoffman, E.P. (2008) Dystrophin-deficient cardiomyopathy in mouse: Expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart. Neuromuscul. Disord., 18, 371-381
30. Massagué, J., Cheifetz, S., Endo, T. and Nadal-Ginard, B. (1986) Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl Acad. Sci. USA, 83, 8206-8210
31. Shen, J., Abel, E.L., Riggs, P.K., Repass, J., Hensley, S.C., Schroeder, L.J., Temple, A., Chau, A., McClellan, S.A. and Rho, O. (2012) Proteomic and pathway analyses reveal a network of inflammatory genes associated with differences in skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice. Carcinogenesis, 33, 2208-2219
32. Heydemann, A., Huber, J.M., Demonbreun, A., Hadhazy, M. and McNally, E.M. (2005) Genetic background influences muscular dystrophy. Neuromuscul. Disord., 15, 601-609
33. James, K. (1967) A simple silver method for the demonstration of reticulin fibres. J. Med. Lab. Technol., 24, 49